Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2016 Feb 4;36(4):750–756. doi: 10.1161/ATVBAHA.115.306647

Table 4.

Associations between Lp-PLA2 and incident low ankle-brachial index*

Incident Cases of Low ABI Model 1 Model 2

OR (95% CI) OR (95% CI)
Lp-PLA2 Mass, ng/ml (n=3537)
1st quartile (57.5–255.1) 51 1.0 (Referent) 1.0 (Referent)
2nd quartile (255.1–325.2) 41 0.94 (0.61, 1.46) 0.91 (0.58, 1.44)
3rd quartile (325.3–402.3) 53 1.42 (0.93, 2.17) 1.34 (0.86, 2.08)
4th quartile (402.3–944.3) 67 1.69 (1.12, 2.56) 1.49 (0.96, 2.30)

Per SD (117.4) 1.22 (1.07, 1.40) 1.16 (1.00, 1.33)
p-value (linear) .004 .046

Lp-PLA2 Activity, nmol/min/ml (n=3537)
1st quartile (8.6–30.2) 57 1.0 (Referent) 1.0 (Referent)
2nd quartile (30.2–37.4) 37 0.75 (0.48, 1.17) 0.67 (0.42, 1.07)
3rd quartile (37.4–46.3) 49 1.15 (0.76, 1.76) 0.96 (0.61, 1.53)
4th quartile (46.3–146.7) 69 1.79 (1.18, 2.71) 1.45 (0.89, 2.35)

Per SD (13.0) 1.32 (1.16, 1.52) 1.28 (1.09, 1.50)
p-value (linear) <.001 .002
*

Results of multivariable logistic regression models are shown for both Lp-PLA2 mass and activity by quartiles of the distribution, with each Lp-PLA2 quartile compared with the 1st quartile (referent quartile), and per standard deviation increment

Model 1 adjusted for age (years), male sex, black, clinic site and time between ABI measures

Model 2 adjusted for Model 1 + cigarette smoking, cardiovascular disease, diabetes, total cholesterol, HDL-c, hypertension, statin use, physical activity, CRP, and eGFR